SALIX PHARMACEUTICALS LTD
DelistedCIK 1009356fmd_0GMPNRTFKAVY71ARD0SY1RVAVYManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Dec 31, 2014, 21 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 |
|---|---|---|---|---|---|---|
| Total revenues | 233 | 337 | 540 | 735 | 914 | 1,134 |
| Cost of revenue | 52 | 69 | 95 | 125 | 178 | 338 |
| Gross profit | 181 | 268 | 445 | 611 | 736 | 796 |
| Research and development | 89 | 73 | 72 | 85 | 113 | 170 |
| Selling, general and administrative | 120 | 156 | 219 | 296 | 342 | 660 |
| Operating income | (40) | (6) | 116 | 172 | 252 | (490) |
| Interest expense | 7 | 21 | 32 | 56 | 62 | 171 |
| Interest and investment income | 1 | 3 | 2 | 11 | 2 | – |
| Other non-operating income (expense) | – | – | – | 11 | 2 | (3) |
| Income before taxes | (46) | (24) | 86 | 112 | 192 | (664) |
| Income tax expense | (2) | 3 | (1) | 48 | 61 | (249) |
| Net income from continuing operations | (44) | (27) | 87 | 64 | 131 | (415) |
| Net income | (44) | (27) | 87 | 64 | 131 | (415) |